110 related articles for article (PubMed ID: 29037838)
1. Expression and epigenetic regulation of cystatin B in lung cancer and colorectal cancer.
Ma Y; Chen Y; Petersen I
Pathol Res Pract; 2017 Dec; 213(12):1568-1574. PubMed ID: 29037838
[TBL] [Abstract][Full Text] [Related]
2. Expression and promoter DNA methylation of MLH1 in colorectal cancer and lung cancer.
Ma Y; Chen Y; Petersen I
Pathol Res Pract; 2017 Apr; 213(4):333-338. PubMed ID: 28214209
[TBL] [Abstract][Full Text] [Related]
3. Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway.
Wang X; Gui L; Zhang Y; Zhang J; Shi J; Xu G
Int J Oncol; 2014 Apr; 44(4):1099-106. PubMed ID: 24452274
[TBL] [Abstract][Full Text] [Related]
4. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation.
Chen Y; Cui T; Knösel T; Yang L; Zöller K; Petersen I
Lung Cancer; 2011 Jul; 73(1):38-44. PubMed ID: 21095038
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor‑β/miR‑143‑3p/cystatin B axis is a therapeutic target in human ovarian cancer.
Guan W; Wang X; Lin Q; Zhang J; Ren W; Xu G
Int J Oncol; 2019 Jul; 55(1):267-276. PubMed ID: 31180557
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of ANKRD18B in lung cancer.
Liu WB; Han F; Jiang X; Yin L; Chen HQ; Li YH; Liu Y; Cao J; Liu JY
Mol Carcinog; 2015 Apr; 54(4):312-21. PubMed ID: 24249358
[TBL] [Abstract][Full Text] [Related]
9. NPTX1 is a novel epigenetic regulation gene and associated with prognosis in lung cancer.
Zhou C; Qin Y; Xie Z; Zhang J; Yang M; Li S; Chen R
Biochem Biophys Res Commun; 2015 Mar; 458(2):381-6. PubMed ID: 25646694
[TBL] [Abstract][Full Text] [Related]
10. Methylation of
Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
[TBL] [Abstract][Full Text] [Related]
11. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
[TBL] [Abstract][Full Text] [Related]
12. Expression of desmogleins 1-3 and their clinical impacts on human lung cancer.
Saaber F; Chen Y; Cui T; Yang L; Mireskandari M; Petersen I
Pathol Res Pract; 2015 Mar; 211(3):208-13. PubMed ID: 25468811
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression and demethylation of gamma-synuclein in colorectal cancer, correlated with progression of the disease.
Ye Q; Zheng MH; Cai Q; Feng B; Chen XH; Yu BQ; Gao YB; Ji J; Lu AG; Li JW; Wang ML; Liu BY
Cancer Sci; 2008 Oct; 99(10):1924-32. PubMed ID: 19016751
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
[TBL] [Abstract][Full Text] [Related]
17. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological significance of REIC expression in colorectal carcinomas.
Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic alterations are involved in the overexpression of glutathione S-transferase π-1 in human colorectal cancers.
Zhang R; Kang KA; Piao MJ; Kim KC; Zheng J; Yao CW; Cha JW; Maeng YH; Chang WY; Moon PG; Baek MC; Hyun JW
Int J Oncol; 2014 Sep; 45(3):1275-83. PubMed ID: 24970398
[TBL] [Abstract][Full Text] [Related]
20. Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.
Kang N; Choi SY; Kim YK; Yoo IeR; Han DH; Lee DS; Kim YS; Hong SH; Kang JH; Lee KY; Park JK; Sung SW; Park MS; Yim HW; Kim SJ; Park JY
Lung Cancer; 2015 Aug; 89(2):99-103. PubMed ID: 26101014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
